The Board of Directors of Krishna Institute of Medical Sciences Limited (KIMS), in their meeting held on May 15, 2026, approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The company reported revenue from operations of 4,562 million for the quarter ended March 31, 2026. A comparative analysis of these financial results reveals fluctuations in performance on a Quarter-on-Quarter (QoQ) and Year-on-Year (YoY) basis.

Krishna Institute of Medical Sciences Limited (KIMS) is one of the leading healthcare providers in the Indian states of Andhra Pradesh and Telangana, with an expanding presence in Maharashtra, Karnataka, and Kerala. The company operates a network of hospitals offering multi-specialty tertiary care and has gained recognition for its clinical excellence and medical infrastructure. Key investors in the company include several major institutional entities such as SBI Mutual Fund, Axis Mutual Fund, HDFC Mutual Fund, Kotak Fund, and Nomura.